Heres what we know from the available data thus far: No reported toxicity in preclinical injection studies No behavioral or pathological abnormalities observed No adverse safety signals in topical skin care studies Theoretical concerns about copper overload exist, but no study to date has demonstrated this outcome with GHK-Cu
Some of these required hospitalization
Background: Incretins were discovered after it was observed that administration of an oral glucose load leads to a much greater stimulation of insulin release than a comparable glucose load given intravenously (Hansotia & Drucker, 2005)
This trend questions the appropriateness of prescribing these medications for short-term use as it is not recommended based on lack of scientific evidence
Pregnancy or breastfeeding : They may harm the fetus or pass into breast milk
Tissue Regeneration: This remarkable peptide supports tissue regeneration by upregulating the expression of growth hormone receptors in various cell types, including those found in tendons, muscles, ligaments, bones, and the gastrointestinal tract [2]